CLINICAL INERTIA IN T2DM ASSESSMENT TOOL

Are your decisions to delay treatment intensification clinical inertia or “appropriate inaction?” Is obesity management a primary treatment goal for your patients with T2DM? Assess how effective you are in achieving short- and long-term therapeutic goals for your patients through this clinical assessment tool and walk away with personalized recommendations and education to address inertia through weight-centric treatment strategies.

Login today to take the assessment, get your personalized report card, and see how you compare to your peers

Or hear from our Faculty to learn more about this assessment

    

Robert Kushner, MD

  • Professor of Medicine and Medical Education
  • Northwestern University Feinberg School of Medicine
  • Director, Center for Lifestyle Medicine
  • Northwestern Medicine
  • Chicago, IL

Donna Ryan, MD

  • Professor Emerita
  • Pennington Biomedical
  • Baton Rouge, LA

Not interested in the assessment? Check out this companion CME activity where these expert faculty share best practices for managing patients with dysglycemia and obesity.

Sponsor Information

Sponsored by the Academy for Continued Healthcare Learning.

Supporter Information

Supported by an educational grant from Lilly.

Program Manager

Laurie Novoryta
Lnovoryta@achlcme.org